Company Guided Therapeutics, Inc.
Equities
GTHP
US40171F5017
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.09 USD | -10.00% | -5.26% | -41.37% |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Non-invasive Cervical Cancer Detection Device
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +653.85% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China, Southeast Asia (including Indonesia), Central & Eastern Europe and Saudi Arabia
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +653.85% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Mark Faupel
CEO | Chief Executive Officer | 68 | 92-10-26 |
Founder | 68 | 92-10-26 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
John Imhoff
BRD | Director/Board Member | 74 | 06-04-09 |
Richard Blumberg
BRD | Director/Board Member | 67 | 16-11-09 |
Mark Faupel
CEO | Chief Executive Officer | 68 | 92-10-26 |
Michael James
CHM | Chairman | 65 | 07-02-28 |
Alan Grujic
BRD | Director/Board Member | 56 | 23-03-07 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 900 | 0 | 0 | 56.26 % |
Stock B | 0 | 400 | 0 | 0 | |
Stock C | 0 | 2,700 | 0 | 0 | |
Stock D | 0 | 1,000 | 0 | 0 | |
Stock E | 0 | 300 | 0 | 0 | |
Stock F | 1 | 55,685,464 | 31,327,583 ( 56.26 %) | 0 | |
Stock G | 0 | 500 | 0 | 0 |
Company contact information
Guided Therapeutics, Inc.
5835 Peachtree Corners East Suite B
30092, Norcross
+770 242 8723
http://www.guidedinc.comSector
1st Jan change | Capi. | |
---|---|---|
-41.37% | 5.02M | |
+12.15% | 227B | |
+14.90% | 197B | |
+18.22% | 141B | |
+29.15% | 110B | |
+0.53% | 64.15B | |
+16.92% | 53.72B | |
+6.33% | 51.75B | |
+10.93% | 45.2B | |
+5.87% | 37.37B |
- Stock Market
- Equities
- GTHP Stock
- Company Guided Therapeutics, Inc.